SCHEMBL6629074

SCHEMBL6629074

COC(=O)c1ccc2cc(CCO)oc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.54
CYP4A11 Q02928 4/20 0.49
CYP4F2 P78329 3/20 0.49
PSMB8 P28062 1/20 0.48
HDAC1 Q13547 2/20 0.46
HDAC3 O15379 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
CREBBP Q92793 1/20 0.46
NPC1 O15118 2/20 0.45
ALDH1A1 P00352 2/20 0.42
NQO2 P16083 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
XDH P47989 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31683130 1.00 HDAC6 (0.54) HDAC6CYP4A11CYP4F2PSMB8HDAC1
SCHEMBL5031812 0.93 HDAC6 (0.54) HDAC6CYP4A11CYP4F2PSMB8HDAC1
SCHEMBL5034750 0.92 CYP4A11 (0.52) HDAC6CYP4A11CYP4F2PSMB8HDAC1
SCHEMBL5030987 0.90 HDAC6 (0.51) HDAC6CYP4A11CYP4F2PSMB8HDAC1
SCHEMBL5030400 0.90 HDAC6 (0.51) HDAC6CYP4A11CYP4F2PSMB8HDAC1
SCHEMBL10290842 0.89 HDAC6 (0.50) HDAC6CYP4A11CYP4F2PSMB8HDAC1
SCHEMBL5031390 0.89 HDAC6 (0.50) HDAC6CYP4A11CYP4F2PSMB8HDAC1
SCHEMBL31683272 0.88 HDAC6 (0.68) HDAC6CYP4A11CYP4F2PSMB8HDAC1
SCHEMBL5674694 0.86 HDAC6 (0.48) HDAC6PSMB8HDAC1HDAC3HDAC2
SCHEMBL5028015 0.85 HDAC6 (0.47) HDAC6CYP4A11CYP4F2PSMB8HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1476448-A2 AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-11-17 EP disclosed
WO-2003070731-A2 AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2003-08-28 WO disclosed